Instead of making doctors plead their case first to companies and then to the FDA, the FDA will become the initial step and will assign a staffer to quickly do the paperwork.
By Marilynn Marchione, AP Chief Medical Writer
Multi-drug-resistant tuberculosis kills nearly half its victims, even when treated with second-line drugs. Patients can beat it, but the road isn’t easy.
By Caleb Hellerman, Janet Tobias, Global Health Reporting Center
Dozens of doctors, medical ethicists, and lawyers are warning Congress that legislation to allow Americans with life-threatening conditions access to unapproved, experimental drugs risks harming patients’ health.
By Ike Swetlitz, STAT
A clinical trial in Guinea found that an experimental vaccine was 75 to 100 percent effective in blocking new infections of the Ebola virus. Hari Sreenivasan speaks to Dr. Anthony Fauci of the National Institutes of Health about the vaccine.
By PBS NewsHour
By PBS NewsHour
The 33-year-old American doctor Kent Brantley was infected with the Ebola virus while working in a hospital in Liberia, but has reportedly made a full recovery. Standing alongside the medical team that treated him in Atlanta’s Emory University Hospital, Brantley…
The world’s worst outbreak of the deadly Ebola virus has now claimed the lives of more than 1,200 people, the World Health Organization said Tuesday. While the disease has carved a destructive path through several West African nations, Liberia recorded…
Judy Woodruff leads a conversation with Lawrence Gostin of Georgetown Law and Jonathan Moreno of the University of Pennsylvania on using untested drugs to fight the Ebola outbreak in West Africa, the possibility of a new experimental vaccine from Canada,…
An ethics panel of the World Health Organization unanimously approved using untested drugs to treat Ebola in West Africa, where more than 1,000 people have died from the outbreak so far. A shipment of the U.S.-made drug ZMapp is expected…
The treatment of two Ebola-infected Americans with an experimental drug, Z-Mapp, raises the question of whether it has potential for widespread use in combating the outbreak in West Africa. Judy Woodruff gets perspective on the topic from two experts, Dr.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.